18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
about
The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancerAn observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer.Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abirateroneBony metastases: assessing response to therapy with whole-body diffusion MRI.Circulating tumor cells in non-small cell lung carcinomaCirculating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis.Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.Monitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?Differential drug responses of circulating tumor cells within patient blood.Nanobiotechnology for the capture and manipulation of circulating tumor cells.MRI for response assessment in metastatic bone disease.Research opportunities in intraoperative radiation therapy: the next decade 2013-2023.Controversies in circulating tumor cell count during therapy.Circulating tumor cells: utopia or reality?Personalized therapy for breast cancer: a dream or a reality?(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.Therapy monitoring of skeletal metastases with whole-body diffusion MRI.Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.Clinical application of circulating tumor cells in breast cancer
P2860
Q34569318-EC0DE1B5-6788-477A-939D-7B9E62844360Q34826007-34E08A62-07D3-47B0-BB25-38F0882198DFQ35068005-69F64104-F45E-46E4-AF85-B7AA5F8D570BQ35697593-75B39A1C-8C0C-4D94-AD17-D53015BCCB84Q36287629-5B177C29-BE3C-4668-80C7-3E728B06DB21Q36551186-5D621B98-C2C9-41F4-B623-81D9609E1E19Q37482604-A9EF37A7-69BC-4D5B-9DCD-2F8B32349025Q37709420-D8F22274-5A66-47B6-AB63-E1BA5E0D43FBQ37716195-AFC970AC-04AA-462A-8E48-C45DF54A2C90Q37719909-3AA5E297-0005-425D-91FC-3B49C52AC04EQ37967661-9E859AE2-CB98-4524-A2EC-87BCA51CB0DFQ38086042-3762114E-6C59-4CFC-BF47-11D69B43120AQ38086807-65A423F8-F6F3-47B4-B5BC-B2F00ACCA3E4Q38115624-D7864B83-1F09-491A-A16C-A75CB4B227A5Q38131799-8445B6A8-FBCF-4085-9C12-2CE928609C7EQ39374969-1941772D-44B0-43F0-AC03-B76CEC384047Q41161118-51E477E8-C21C-4A33-84FA-147261F07D3BQ51114179-499D91A5-C96F-458E-88DE-EA7EDD470D92Q53165455-9FF8B772-25F4-4099-AEB0-39AF521C70E8Q57129057-03E42DA1-BDA0-442C-81F3-BCAA72EEFE4C
P2860
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
18F-FDG PET/CT findings and ci ...... metastases from breast cancer.
@en
18F-FDG PET/CT findings and ci ...... metastases from breast cancer.
@nl
type
label
18F-FDG PET/CT findings and ci ...... metastases from breast cancer.
@en
18F-FDG PET/CT findings and ci ...... metastases from breast cancer.
@nl
prefLabel
18F-FDG PET/CT findings and ci ...... metastases from breast cancer.
@en
18F-FDG PET/CT findings and ci ...... metastases from breast cancer.
@nl
P2093
P1476
18F-FDG PET/CT findings and ci ...... metastases from breast cancer.
@en
P2093
Beverly C Handy
Eric M Rohren
Gabriel N Hortobagyi
Homer A Macapinlac
James M Reuben
Massimo Cristofanilli
Michal Mego
Naoto T Ueno
Ugo De Giorgi
P304
P356
10.2967/JNUMED.110.076455
P407
P577
2010-07-21T00:00:00Z